Beijing Strong Biotech Grants Technology License to Abbott

Beijing Strong Biotechnologies (BSBE) recently signed a technology license granting Abbott Labs rights to its clinical chemistry testing products, which BSBE currently manufactures in China. Initially, the agreement gives Abbott rights to 55 products in return for upfront and milestone payments, plus royalties on sales for a specified period. In addition, Abbott will have the right to add additional products over time. Although the agreement was signed in February, it was not widely publicized at the time. Financial details were not disclosed. More details.... Stock Symbols: (SHE: 300406) (NYSE: ABT) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.